Cargando…
Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy
Bacterial superantigens (SAgs) are effective T-cell stimulatory molecules that lead to massive cytokine production. Superantigens crosslink between MHC class II molecules on the Antigen Presenting Cells (APC) and TCR on T-cells. This enables them to activate up to 20% of resting T cells, whilst conv...
Autores principales: | Bashraheel, Sara S., Goda, Sayed K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341475/ https://www.ncbi.nlm.nih.gov/pubmed/37445686 http://dx.doi.org/10.3390/ijms241310507 |
Ejemplares similares
-
Superantigen antagonist peptides
por: Llewelyn, Martin, et al.
Publicado: (2001) -
Detection of Streptococcus pyogenes M1(UK) in Australia and characterization of the mutation driving enhanced expression of superantigen SpeA
por: Davies, Mark R., et al.
Publicado: (2023) -
Human TGFalpha-derived peptide TGFalphaL3 fused with superantigen for immunotherapy of EGFR-expressing tumours
por: Xu, Quanbin, et al.
Publicado: (2010) -
Superantigens: Just Like Peptides Only Different
por: Proft, Thomas, et al.
Publicado: (1998) -
Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
por: Lattanzi, Roberta, et al.
Publicado: (2022)